SCHEMBL4152258

SCHEMBL4152258

FC(F)(F)Oc1cccc(-c2cnc(NCCc3ccncc3)cn2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.52
DYRK1A Q13627 1/20 0.44
SYK P43405 1/20 0.43
PTGDR Q13258 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
FLT1 P17948 5/20 0.40
KDR P35968 5/20 0.40
NPY5R Q15761 1/20 0.40
MAPT P10636 1/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NAMPT P43490 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4139796 0.87 CYP1A2 (0.47) PIM1PTGDRMKNK1MKNK2CYP1A2
SCHEMBL4139867 0.78 TPH1 (0.45) DYRK1APTGDRMKNK1MKNK2ROCK2
SCHEMBL1945468 0.73 FYN (0.66) PIM1DYRK1A
SCHEMBL4139805 0.73 FYN (0.56) PTGDRCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4147501 0.73 CCNT1 (0.46) PTGDRMKNK1MKNK2KDR
SCHEMBL4143605 0.73 HIF1A (0.47) CYP3A4CYP2C9ROCK2ROCK1NAMPT
SCHEMBL1945470 0.73 NAMPT (0.44) PIM1DYRK1ASYKCYP1A2CYP3A4
SCHEMBL4148108 0.72 FYN (0.41) DYRK1APTGDRMKNK1MKNK2MAPT
SCHEMBL4160480 0.71 PDGFRB (0.50) MKNK1MKNK2FLT1KDRMAPT
SCHEMBL4148649 0.69 PTGDR (0.39) PTGDRMKNK1MKNK2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes BIOFOCUS DISCOVERY LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes ROCK1, ROCK2, CIT PIM1 653/4885DYRK1A 1204/4885SYK 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.